Activation and pulmonary toxicity of pyrrolizidine alkaloids
References (157)
- et al.
Effect of age on development of cor pulmonale in non-human primates following pyrrolizidine alkaloid intoxication
Exp. Molec. Path.
(1972) - et al.
Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity
Toxic. appl. Pharmac.
(1986) - et al.
In vivo covalent binding of retronecine-labelled [3H]seneciphylline and [3H]senecionine to DNA of rat liver, lung and kidney
Chem.-Biol. Interactions
(1985) - et al.
Right ventricular hypertrophy in monocrotaline pyrrole treated rats
Exp. molec. Path.
(1974) - et al.
Monokine-induced lung injury in rats: Similarities to monocrotaline-induced pneumotoxicity
Toxic. appl. Pharmac.
(1989) - et al.
Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in rats
Toxic. Lett.
(1984) - et al.
Effects of monocrotaline treatment on norepinephrine removal by isolated, perfused rat lungs
Biochem. Pharmac.
(1984) New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids
Gen. Pharmac.
(1979)Problems with pyrrolizidines
TIPS
(1980)- et al.
The prevention of monocrotaline-induced right ventricular hypertrophy
Chest
(1977)
Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertension
Exp. molec. Path.
(1989)
The formation of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkaloids
Chem.-Biol. Interactions
(1986)
Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline
Toxicon
(1985)
Monocrotaline-induced pulmonary arteritis in rats
J. Atheroscler. Res.
(1962)
Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids
Chem.-Biol. Interactions
(1972)
The distribution of (3H)synthanecine A bis-N-ethylcarbamate and its metabolites in the rat
Chem.-Biol. Interactions
(1976)
Antimitotic effects of dehydroretronecine pyrrole
Dehydroretronecine-induced rhabdomyosarcomas in rats
Cancer Res.
(1975)
Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension
J. Pharmac. exp. Ther.
(1986)
The nature of the bradykinin inactivating system in isolated lungs
Br. J. Pharmac.
(1976)
Lesions in the lungs and livers of rats poisoned with the pyrrolizidine alkaloid fulvine and its N-oxide
J. Path. Bact.
(1964)
Mechanism of hypoxic injury to pulmonary artery endothelial cell plasma membranes
Am. J. Physiol.
(1989)
Effects of changes in extra- and intracellular K+ on the endothelial production of prostacyclin
Br. J. Pharmac.
(1989)
Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs
Circulation
(1984)
Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat
Am. J. Physiol.
(1983)
Differences in K+-induced relaxation of canine femoral and renal arteries
Am. J. Physiol.
(1983)
The heart and pulmonary arteries in rat fed on Senecio jacobaea
J. Path.
(1972)
Monocrotaline-induced pulmonary hypertension and p-chlorophenylalanine (PCPA)
Lab. Invest.
(1969)
Pyrrolizidine (Senecio) alkaloids: Toxicity, Metabolism, and Poisonous Plant Control Measures
(1979)
Toxicants of Plant Origin: I Alkaloids
(1989)
Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides)
Am. J. Vet. Res.
(1973)
Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung
Histochemistry
(1974)
Low-dose PGI2 prevents monocrotaline-induced thromboxane production and lung injury
J. appl. Physiol.
(1986)
Biochemical properties of the endothelium-derived growth factor. Comparison to other growth factors
J. cell. Physiol.
(1983)
Attenuation of the toxicity of a pyrrolizidine alkaloid, monocrotaline, by metabolic inhibition
Neither anticoagulant nor anticoagulant heparin affects monocrotaline lung injury
J. appl. Physiol.
(1987)
Ventricular weight in cardiac hypertrophy
Br. Heart J.
(1952)
The role of the endothelium in the response of vascular smooth muscle to drugs
A. Rev. Pharmac. Toxic.
(1984)
Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole
Am. J. Physiol.
(1987)
6-Ketoprostaglandin F1 and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline treated rats
J. Toxic. environ. Hlth
(1988)
Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin
J. Pharmac. exp. Ther.
(1986)
Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia
Am. J. Physiol.
(1988)
Changes in pulmonary structure and function induced by monocrotaline intoxication
Am. J. Physiol.
(1981)
α-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs
Res. Commun. Chem. Path. Pharmac.
(1985)
Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats
Am. J. Physiol.
(1986)
Interleukin I bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension
Effect of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and norepinephrine by perfused lung
Br. J. Pharmac.
(1978)
Role of cellular calcium homeostasis in toxic liver injury induced by the pyrrolizidine alkaloid senecionine, and the alkenal, trans-4-OH-2-hexenal
J. Biochem. Toxic.
(1987)
The Human Pulmonary Circulation
(1962)
The action of monocrotaline and retronecine
J. Pharmac. exp. Ther.
(1942)
Cited by (99)
Comprehensive overview of the analytical methods for determining pyrrolizidine alkaloids and their derived oxides in foods
2024, Journal of Food Composition and AnalysisHypoxia modeling techniques: A review
2023, HeliyonCharacterization of liver injury induced by a pyrrolizidine alkaloid in rats
2021, PhytomedicineTransfer of pyrrolizidine alkaloids between living plants: A disregarded source of contaminations
2019, Environmental Pollution
Copyright © 1990 Published by Elsevier Inc.